154 related articles for article (PubMed ID: 32927005)
1. Effect of trehalose and melibiose on crystallization of amorphous paracetamol.
Palomäki EAK; Lipiäinen T; Strachan CJ; Yliruusi JK
Int J Pharm; 2020 Nov; 590():119878. PubMed ID: 32927005
[TBL] [Abstract][Full Text] [Related]
2. Evaluate the ability of PVP to inhibit crystallization of amorphous solid dispersions by density functional theory and experimental verify.
Wang B; Wang D; Zhao S; Huang X; Zhang J; Lv Y; Liu X; Lv G; Ma X
Eur J Pharm Sci; 2017 Jan; 96():45-52. PubMed ID: 27568852
[TBL] [Abstract][Full Text] [Related]
3. Phase behavior of amorphous molecular dispersions I: Determination of the degree and mechanism of solid solubility.
Vasanthavada M; Tong WQ; Joshi Y; Kislalioglu MS
Pharm Res; 2004 Sep; 21(9):1598-606. PubMed ID: 15497685
[TBL] [Abstract][Full Text] [Related]
4. Investigation into Intermolecular Interactions and Phase Behavior of Binary and Ternary Amorphous Solid Dispersions of Ketoconazole.
Sarpal K; Tower CW; Munson EJ
Mol Pharm; 2020 Mar; 17(3):787-801. PubMed ID: 31860316
[TBL] [Abstract][Full Text] [Related]
5. Investigation of recrystallization of amorphous trehalose through hot-humidity stage X-ray powder diffraction.
Jójárt-Laczkovich O; Katona G; Aigner Z; Szabó-Révész P
Eur J Pharm Sci; 2016 Dec; 95():145-151. PubMed ID: 27496047
[TBL] [Abstract][Full Text] [Related]
6. Characterization of Phase Separation Propensity for Amorphous Spray Dried Dispersions.
McNamara D; Yin S; Pan D; Crull G; Timmins P; Vig B
Mol Pharm; 2017 Feb; 14(2):377-385. PubMed ID: 28068097
[TBL] [Abstract][Full Text] [Related]
7. Development of fully amorphous dispersions of a low T(g) drug via co-spray drying with hydrophilic polymers.
Zhao M; Barker SA; Belton PS; McGregor C; Craig DQ
Eur J Pharm Biopharm; 2012 Nov; 82(3):572-9. PubMed ID: 22922419
[TBL] [Abstract][Full Text] [Related]
8. Physical stability of l-ascorbic acid amorphous solid dispersions in different polymers: A study of polymer crystallization inhibitor properties.
Christina B; Taylor LS; Mauer LJ
Food Res Int; 2015 Oct; 76(Pt 3):867-877. PubMed ID: 28455073
[TBL] [Abstract][Full Text] [Related]
9. Obtaining two polymorphic forms of paracetamol within the phase diagram with PEG 1500.
Rassat M; Ouandji I; Guiblin N; Espeau P
Eur J Pharm Biopharm; 2024 Feb; 195():114173. PubMed ID: 38145856
[TBL] [Abstract][Full Text] [Related]
10. Preparation and characterization of azithromycin--Aerosil 200 solid dispersions with enhanced physical stability.
Li X; Peng H; Tian B; Gou J; Yao Q; Tao X; He H; Zhang Y; Tang X; Cai C
Int J Pharm; 2015; 486(1-2):175-84. PubMed ID: 25794608
[TBL] [Abstract][Full Text] [Related]
11. An investigation into the effect of spray drying temperature and atomizing conditions on miscibility, physical stability, and performance of naproxen-PVP K 25 solid dispersions.
Paudel A; Loyson Y; Van den Mooter G
J Pharm Sci; 2013 Apr; 102(4):1249-67. PubMed ID: 23359268
[TBL] [Abstract][Full Text] [Related]
12. Spectroscopic Investigation of the Formation and Disruption of Hydrogen Bonds in Pharmaceutical Semicrystalline Dispersions.
Van Duong T; Reekmans G; Venkatesham A; Van Aerschot A; Adriaensens P; Van Humbeeck J; Van den Mooter G
Mol Pharm; 2017 May; 14(5):1726-1741. PubMed ID: 28363028
[TBL] [Abstract][Full Text] [Related]
13. On the inherent properties of Soluplus and its application in ibuprofen solid dispersions generated by microwave-quench cooling technology.
Shi NQ; Lai HW; Zhang Y; Feng B; Xiao X; Zhang HM; Li ZQ; Qi XR
Pharm Dev Technol; 2018 Jul; 23(6):573-586. PubMed ID: 27824281
[TBL] [Abstract][Full Text] [Related]
14. Solvent-shift strategy to identify suitable polymers to inhibit humidity-induced solid-state crystallization of lacidipine amorphous solid dispersions.
Sun M; Wu C; Fu Q; Di D; Kuang X; Wang C; He Z; Wang J; Sun J
Int J Pharm; 2016 Apr; 503(1-2):238-46. PubMed ID: 26869398
[TBL] [Abstract][Full Text] [Related]
15. Solubility and Physical Stability Enhancement of Loratadine by Preparation of Co-Amorphous Solid Dispersion with Chlorpheniramine and Polyvinylpyrrolidone.
Suknuntha K; Khumpirapang N; Tantishaiyakul V; Okonogi S
Pharmaceutics; 2023 Oct; 15(11):. PubMed ID: 38004537
[TBL] [Abstract][Full Text] [Related]
16. Phase behavior of poly(vinylpyrrolidone) containing amorphous solid dispersions in the presence of moisture.
Rumondor AC; Marsac PJ; Stanford LA; Taylor LS
Mol Pharm; 2009; 6(5):1492-505. PubMed ID: 19634917
[TBL] [Abstract][Full Text] [Related]
17. Thermoanalytical and Fourier transform infrared spectral curve-fitting techniques used to investigate the amorphous indomethacin formation and its physical stability in Indomethacin-Soluplus® solid dispersions.
Lin SY; Lin HL; Chi YT; Huang YT; Kao CY; Hsieh WH
Int J Pharm; 2015 Dec; 496(2):457-65. PubMed ID: 26481469
[TBL] [Abstract][Full Text] [Related]
18. Spray drying ternary amorphous solid dispersions of ibuprofen - An investigation into critical formulation and processing parameters.
Ziaee A; Albadarin AB; Padrela L; Faucher A; O'Reilly E; Walker G
Eur J Pharm Biopharm; 2017 Nov; 120():43-51. PubMed ID: 28822874
[TBL] [Abstract][Full Text] [Related]
19. Anomalous dissolution behavior of celecoxib in PVP/Isomalt solid dispersions prepared using spray drier.
Ghanavati R; Taheri A; Homayouni A
Mater Sci Eng C Mater Biol Appl; 2017 Mar; 72():501-511. PubMed ID: 28024614
[TBL] [Abstract][Full Text] [Related]
20. Investigation of Drug-Excipient Interactions in Biclotymol Amorphous Solid Dispersions.
Schammé B; Couvrat N; Tognetti V; Delbreilh L; Dupray V; Dargent É; Coquerel G
Mol Pharm; 2018 Mar; 15(3):1112-1125. PubMed ID: 29328661
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
